Download Scientific Programme

yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Hospital-acquired infection wikipedia, lookup

Sociality and disease transmission wikipedia, lookup

Infection wikipedia, lookup

Neonatal infection wikipedia, lookup

Schistosomiasis wikipedia, lookup

Marburg virus disease wikipedia, lookup

Germ theory of disease wikipedia, lookup

Globalization and disease wikipedia, lookup

Transmission (medicine) wikipedia, lookup

Triclocarban wikipedia, lookup

Gastroenteritis wikipedia, lookup

Clostridium difficile infection wikipedia, lookup

Infection control wikipedia, lookup

Human cytomegalovirus wikipedia, lookup

Antimicrobial copper-alloy touch surfaces wikipedia, lookup

Antimicrobial surface wikipedia, lookup

Urinary tract infection wikipedia, lookup

Anaerobic infection wikipedia, lookup

Antibiotics wikipedia, lookup

Carbapenem-resistant enterobacteriaceae wikipedia, lookup

Staphylococcus aureus wikipedia, lookup

Poster Sessions
Saturday, 7 May
Prevalence of carbapenem-resistant
Enterobacteriaceae and carbapenem-resistant
Pseudomonas aeruginosa and Acinetobacter
baumannii in routine ESBL surveillance
M. Pirs*, A. Andlovic, T. Cerar, T. Furlan,
J. Guzej, K. Seme (Ljubljana, SI)
Evaluation of a new gradient-diffusion
system for MIC determination with
Gram-negative pathogens
V. Conte, M.M. D'Andrea, T. Giani, G.M. Rossolini*
(Siena, IT)
In vitro activity of piperacillin-tazobactam
and comparators against P. aeruginosa in
countries of Eastern Europe, 2006–2010
S. Lob, S. Bouchillon, R. Badal, D. Hoban*,
S. Hawser, M. Hackel, M. Dowzicky
(Schaumburg, US; Epalinges, CH; Collegeville, US)
Surveillance of antimicrobial susceptibility
of Pseudomonas aeruginosa isolates from
a central hospital in central Portugal:
7 years of evolution or involution?
S.G. Pereira*, H. Oliveira, L. Albuquerque,
R. Leitão, O. Cardoso on behalf of the Center
for Pharmaceutical Studies
Resistance rates of Pseudomonas aeruginosa
clinical isolates in a tertiary hospital
S. Tsiplakou, A. Stylianakis, V. Papaioannou,
P. Thomaidis, E. Chatziandreou, C. Karra,
A. Koutsoukou* (Athens, GR)
Activity of colistin against European
P. aeruginosa from the TEST Study: 2009 – 2010
M. Hackel, D. Hoban*, B. Johnson, S. Bouchillon,
J. Johnson, S. Hawser, M. Dowzicky
(Schaumburg, US; Epalinges, CH; Collegeville, US)
Population structure of clinical and
environmental Pseudomonas aeruginosa
isolates from five Mediterranean countries
M. Maatallah, A. Bakhrouf, C. Giske*
(Monastir, TN; Stockholm, SE)
15:30 – 16:30
Helicobacter pylori infections: from diagnosis
to pathogenesis
Can Helicobacter pylori reside in the human
oral cavity?
A. Al-Ahmad*, A. Kürschner, A. Wittmer,
E. Hellwig, M. Kist, B. Waidner (Freiburg, DE)
Assessment of peroxisome proliferatoractivated receptor-gamma polymorphisms in
Helicobacter pylori infected patients
H. Goudarzi* (Tehran, IR)
21st ECCMID / 27th ICC / Milan
Final Programme
Detection of H. pylori and clarithromycin
and/or fluoroquinolone resistance in gastric
biopsies by Genotype® HelicoDR
T. Alarcon*, A. Somodevilla, S. Agudo,
P. Urruzuno, M.J. Martinez, M. Lopez-Brea
(Madrid, ES)
Cytokine levels in serum of patients with
gastric pathologic infected with Helicobacter
pylori cagA negative and cagA positive
D. Ortiz Princz*, O. Rodríguez, M. Cavazza
(Caracas, VE)
Prevalence and distribution of virulence
factor jhp0562 and jhp0563 genes among
Spanish Helicobacter pylori clinical isolates
Á. Somodevilla*, T. Alarcón, E. Aznar,
M.J. Martínez, M. López-Brea (Madrid, ES)
Molecular characterisation of Helicobacter
pylori associated to different gastric
pathology in adult Moroccan population:
prospective study
S. Alaoui, B. Bennani, M. Mahmoud*, M. Lahbabi,
D. Benajah, M. El Abkari, A. Ibrahimi, H. Belghiti,
A. Amarti, K. El Ghazi, C. Nejjari, A. Souleimani
(Fez, MA)
Prevalence of virulence factor HomB among
Spanish Helicobacter pylori clinical isolates
Á. Somodevilla*, T. Alarcón, M. Espínola,
P. Urruzuno, M. López-Brea (Madrid, ES)
Mice immune responses to UreB332-HpaA,
a recombinant fusion protein from Helicobacter
B. Hajikhani*, S. Najar Peerayeh,
H. Soleimanjahi, Z. Hassan (Tehran, IR)
15:30 – 16:30
Diagnosis of gastrointestinal infections
Prospective application of the Luminex
xTAG®-GPP multiplex PCR in diagnosing
infectious gastroenteritis
E. Wessels, L. Rusman, M. van Bussel, L. Lan,
D. Himsworth, E. Claas* (Leiden, NL; Toronto, CA)
Screening for enteropathogenic Escherichia
coli by an eight-plex PCR of nucleic acids
extracted directly from human stools using
the NorDiag Bullet stool DNA kit
J.K. Møller*, B. Kolmos, M.H. Dahl,
L. Pødenphant, D. Ørnskov (Vejle, DK)
Microarray-based detection of virulence
genes in verotoxic Escherichia coli strains
isolated from human, cattle and food in
A. Januszkiewicz*, J. Szych, J. Osek,
W. Rastawicki (Warsaw, Pulawy, PL)